Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a consumer health company focused on everyday health products (including brands such as Advil, Centrum, and Panadol), covers the month of April 2026. The report specifically details transactions in the company's own shares under a share buyback programme announced on March 12, 2026.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity figures. It focuses exclusively on share repurchase activity.
- Total Shares Purchased: 8,740,351 ordinary shares for cancellation.
- Transaction Period: April 13, 2026, to April 17, 2026.
- Price Range: Highest price paid was 363.70 pence per share; lowest price paid was 351.20 pence per share.
- Volume Weighted Average Price (VWAP): Varied daily between approximately 353.06 pence and 362.42 pence.
- Post-Transaction Capital: Registered share capital stands at 8,911,083,689 ordinary shares of £0.01 each.
- Treasury Shares: 12,320,645 shares held as treasury shares.
- Voting Rights: 8,898,763,044 ordinary shares with voting rights.
Material Changes
The primary material change is the reduction of the company's share count due to the cancellation of 8,740,351 shares purchased during the week of April 13-17, 2026. This activity was executed across multiple trading venues including the London Stock Exchange, CBOE (UK)/BXE, CBOE (UK)/CXE, and Aquis.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on financial performance, or discussion of risks and contingencies. It is a regulatory disclosure of share transactions required under the Market Abuse Regulation (Regulation (EU) No 596/2014 as it applies in the UK).
Key Facts for Investor Verification
- Verify the total number of shares cancelled (8,740,351) against the company's updated share capital count.
- Confirm the current number of shares with voting rights (8,898,763,044) for disclosure threshold calculations under FCA rules.
- Review the detailed trade breakdown available via the provided RNS link for specific execution prices and volumes per venue.
- Note that this filing does not contain financial performance data; refer to the most recent Form 20-F or quarterly earnings release for revenue and profit metrics.